Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Evaluation of Bezlotoxumab for the Management of Clostridioides Difficile Infection

NCT04317963 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT04317963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04317963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Evaluation of Bezlotoxumab for the Management of Clostridioides Difficile Infection
Lead sponsor
University of Illinois at Chicago
Phase
Observational
Overall status
Completed
Start date
February 12, 2020
Completion date
February 22, 2023
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection, clostridium difficile infection recurrence